AntimetabolitesAntimetabolites, AntineoplasticAntineoplastic AgentsFloxuridineTetrahydrouridineNeoplasmsTrabeculectomyInosine MonophosphateFluorouracilDrug Screening Assays, AntitumorPhosphoribosyl PyrophosphateMitomycinMethotrexate6-MercaptopurineLeukemia L1210Folic Acid AntagonistsDrug Resistance, NeoplasmCytarabineCell SurvivalPurinesDrug Evaluation, PreclinicalDrug DiscoveryDrug DesignDrug SynergismTumor Cells, CulturedMolecular Targeted TherapyDeoxycytidineCell CycleEarly Detection of CancerCell Line, TumorProstatic NeoplasmsBreast NeoplasmsDrug IndustryDrug ApprovalDrug Delivery SystemsCell DivisionGene Expression Regulation, NeoplasticDrug CostsFees, PharmaceuticalClinical Trials as TopicDrugs, InvestigationalMice, NudeMedical OncologyUnited States Food and Drug AdministrationCell LineNeoplasm ProteinsCell ProliferationCost SharingPharmacopoeias as TopicOvarian NeoplasmsDrug Resistance, MultipleApoptosisXenograft Model Antitumor AssaysLung NeoplasmsUnited StatesInhibitory Concentration 50NaphthoquinonesStomach NeoplasmsColonic NeoplasmsGene Expression ProfilingProtein Kinase InhibitorsTumor Markers, BiologicalNeoplasm MetastasisNeoplasm InvasivenessPancreatic NeoplasmsCisplatinKineticsSignal TransductionPyrimidinesCancer VaccinesBlotting, WesternDrug CarriersProto-Oncogene Proteins c-ablModels, BiologicalDose-Response Relationship, DrugEnzyme InhibitorsPiperazinesUterine Cervical NeoplasmsSurvival AnalysisGenetic Predisposition to DiseaseSurvival RateBenzamidesP-GlycoproteinPrognosisDoxorubicinAntineoplastic Combined Chemotherapy ProtocolsCarcinomaUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellNational Cancer Institute (U.S.)Disease ProgressionRiskMolecular StructureReverse Transcriptase Polymerase Chain ReactionFollow-Up StudiesColorectal NeoplasmsRetrospective StudiesReceptors, EstrogenRegistries